GLP1R and obesity due to melanocortin 4 receptor deficiency: Interestingly, it has been shown that NMDA receptor antagonism with GLP-1 receptor agonism may effectively reverse the hyper-glycemia, dyslipidemia, and/or obesity in the animal model of metabolic diseases [87].